No prior HCV treatment (Naive)
- clinicaltrial.gov identifier: NCT01297270
- clinicaltrial.gov identifier: NCT01435226
Interferon Ineligible or Intolerant Participants:
- clinicaltrial.gov identifier: NCT01434498
www.clinicaltrials.gov Is a service of the U.S. National Institutes of Health
Mark S. Sulkowski, MD is an Associate Professor of Medicine and serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine in Baltimore, Maryland. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), and completed his Fellowship in Infectious Diseases (1998) at Johns Hopkins University School of Medicine, in Baltimore, Maryland. In addition, Dr. Sulkowski has been the principal investigator for numerous clinical trials related to the management of viral hepatitis including novel agents. He is the co-investigator for adult patients at the Johns Hopkins site of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Hepatitis B Clinical Research Network as well as the National Institute of Allergy and Infectious Diseases Adult AIDS Clinical Trials Group. Dr. Sulkowski is a member of numerous professional societies including American Association for the Study of Liver Diseases, European Association for the Study of the Liver and Infectious Diseases Society of America. He is also an elected member for American Society for Clinical Investigation (ASCI). He is widely published with works in Annals Internal Medicine, Nature, New England Journal of Medicine, Journal of the American Medical Association, Journal of Infectious Diseases, and Hepatology. As an invited lecturer, he has presented discussions of the management of viral hepatitis at numerous, major national and international medical meetings.
Contact us by e-mail or phone for more information:
Ask to be place on our mailing list for exciting news on Hepatitis C.